Chiome Bioscience Inc. (TYO:4583)
Japan · Delayed Price · Currency is JPY 74.00
-2.00 (-2.63%)
Jun 3, 2026, 3:30 PM JST
Chiome Bioscience Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -982.78 | -1,021 | -1,220 | -1,243 | -1,480 |
Depreciation & Amortization | 3.74 | 1.17 | 1.2 | 1.48 | 2.96 |
Loss (Gain) From Sale of Investments | - | - | - | - | 150 |
Other Operating Activities | -0.37 | -32.46 | 7.05 | 22.69 | 22.15 |
Change in Accounts Receivable | -20.93 | 32.13 | 32.02 | -89.76 | 31.32 |
Change in Inventory | -3.24 | 17.94 | 7.37 | -12.49 | 30.21 |
Change in Accounts Payable | 10.25 | -10.54 | 5.87 | 2.06 | -10.3 |
Change in Unearned Revenue | 130.33 | - | - | -4.6 | - |
Change in Other Net Operating Assets | -72.98 | 11.88 | 97.31 | 132.49 | 122.27 |
Operating Cash Flow | -935.99 | -1,001 | -1,069 | -1,191 | -1,131 |
Capital Expenditures | -40.08 | - | - | - | - |
Sale of Property, Plant & Equipment | - | - | 0.17 | - | - |
Other Investing Activities | -15.38 | - | - | - | -35.38 |
Investing Cash Flow | -55.46 | - | 0.17 | - | -35.38 |
Short-Term Debt Issued | - | - | 107 | 1 | 3 |
Long-Term Debt Issued | 200 | - | - | - | - |
Total Debt Issued | 200 | - | 107 | 1 | 3 |
Short-Term Debt Repaid | -194.8 | -9.5 | - | - | - |
Long-Term Debt Repaid | -25 | - | - | - | - |
Total Debt Repaid | -219.8 | -9.5 | - | - | - |
Net Debt Issued (Repaid) | -19.8 | -9.5 | 107 | 1 | 3 |
Issuance of Common Stock | 160.03 | 1,748 | 560.3 | 1,126 | 268.34 |
Repurchase of Common Stock | -7.03 | -0.58 | - | - | - |
Other Financing Activities | -0 | -0 | 0 | -0 | 0 |
Financing Cash Flow | 133.2 | 1,738 | 667.3 | 1,127 | 271.35 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - |
Net Cash Flow | -858.25 | 737.73 | -401.72 | -63.72 | -895.33 |
Free Cash Flow | -976.07 | -1,001 | -1,069 | -1,191 | -1,131 |
Free Cash Flow Margin | -164.52% | -128.16% | -156.67% | -188.81% | -158.68% |
Free Cash Flow Per Share | -14.38 | -17.19 | -21.58 | -27.08 | -28.09 |
Cash Interest Paid | 3.16 | 2.87 | 2.07 | 1.32 | 1.32 |
Cash Income Tax Paid | 2.53 | 5.01 | 5.01 | 3.24 | -4.56 |
Levered Free Cash Flow | -641.7 | -651.57 | -630.68 | -748.1 | -648.68 |
Unlevered Free Cash Flow | -639.73 | -649.78 | -629.39 | -747.27 | -647.86 |
Change in Working Capital | 43.42 | 51.41 | 142.57 | 27.7 | 173.5 |